Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

covis pharma europe b.v. - formoterol fumarate dihydrate, aclidinium bromide - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - brimica genuair on näidustatud kroonilise obstruktiivse kopsuhaiguse (kok) raviks täiskasvanud patsientidel, kes hoiavad bronhodilataatorit õhuvoolu takistamiseks ja sümptomite leevendamiseks..

Estonia - Tiếng Estonia - Ravimiamet

viatris limited - formoterool+beklometasoon - inhalatsiooniaerosool, lahus - 6mcg+100mcg 1annus 120annus 2tk; 6mcg+100mcg 1annus 120annus 1tk

Estonia - Tiếng Estonia - Ravimiamet

pharmaswiss ceska republika s.r.o. - formoterool - inhalatsioonipulber kõvakapslis - 12mcg 60tk; 12mcg 180tk; 12mcg 120tk; 12mcg 30tk

Estonia - Tiếng Estonia - Ravimiamet

orion corporation - formoterool - inhalatsioonipulber - 12mcg 1annus 120annus 2tk

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

covis pharma europe b.v. - aclidinium bromiid, formoterol dietüülfumaraat dihüdraat - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - duaklir genuair on näidustatud bronhe lõõgastavaks säilitusraviks kroonilise obstruktiivse kopsuhaiguse (kok) täiskasvanud patsientidel sümptomite.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol dietüülfumaraat dihüdraat, glycopyrronium bromiid - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol dietüülfumaraat dihüdraat, glycopyrronium - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - asendusravi keskmise või raske krooniline obstruktiivne kopsuhaigus (kok) täiskasvanud patsientidel, kes ei käsitleta piisavalt inhaleeritava kortikosteroidi ja pikatoimelise beta2-agonisti (mõju sümptomid kontrolli ja ägenemiste ennetamine vt lõik 5.

Estonia - Tiếng Estonia - Ravimiamet

orion corporation - formoterool+budesoniid - inhalatsioonipulber - 4,5mcg+80mcg 1annus 60annus 1tk; 4,5mcg+80mcg 1annus 60annus 3tk; 4,5mcg+80mcg 1annus 120annus 1tk; 4,5mcg+80mcg 1annus 120annus 3tk

Estonia - Tiếng Estonia - Ravimiamet

chiesi pharmaceuticals gmbh - formoterool+beklometasoon - inhalatsioonipulber - 6mcg+200mcg 1annus 120annus 2tk; 6mcg+200mcg 1annus 120annus 1tk

Estonia - Tiếng Estonia - Ravimiamet

astrazeneca ab - formoterool+budesoniid - inhalatsioonipulber - 4,5mcg+80mcg 1annus 120annus 3tk; 4,5mcg+80mcg 1annus 60annus 1tk; 4,5mcg+80mcg 1annus 120annus 1tk; 4,5mcg+80mcg 1annus 60annus 18tk; 4,5mcg+80mcg 1annus 60annus 2tk; 4,5mcg+80mcg 1annus 60annus 10tk; 4,5mcg+80mcg 1annus 120annus 10tk; 4,5mcg+80mcg 1annus 120annus 18tk; 4,5mcg+80mcg 1annus 60annus 3tk